Skip to main content
OpenTrials

Clinical trial condition

Loss of Heterozygosity

Explore clinical trials studying Loss of Heterozygosity. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies
Refine in advanced search Browse all conditions

Loss of Heterozygosity trial results

Completed

Rucaparib in Treating Patients With Genomic LOH High and/or Deleterious BRCA1/2 Mutation Stage IV or Recurrent Non-small Cell Lung Cancer (A Lung-MAP Treatment Trial)

NCT03845296

Conditions
Adenocarcinoma, Adenocarcinoma of Lung, Bronchial Neoplasms, +23 more
Locations
  • University of South Alabama Mitchell Cancer Institute Mobile, Alabama, United States
  • Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
  • Anchorage Radiation Therapy Center Anchorage, Alaska, United States
  • Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
View all 950 locations
View Trial Details

Related conditions